Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry

Journal of the American Academy of Dermatology

Volumn 66, Issue 1, 2012, Pages 37-45

  Leiter, Ulrike ^a   Buettner, Petra G ^b   Eigentler, Thomas K ^a   Bröcker, Eva B ^c   Voit, Christiane ^d   Gollnick, Harald ^e   Marsch, Wolfgang ^f   Wollina, Uwe ^g   Meier, Friedegund ^a   Garbe, Claus ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

^f MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^g ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

cutaneous melanoma; hazard rates; recurrences; survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SKIN NEOPLASMS;

EID: 83655167357     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.09.772     Document Type: Article

References (25)

1. C.M. Grin-Jorgensen, D.S. Rigel, and R.J. Friedman The worldwide incidence of malignant melanoma 2nd ed. 1992 JB Lippincott Company Philadelphia p. 27-39
2. M.B. Lens, and M. Dawes Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma Br J Dermatol 150 2004 179 185 (Pubitemid 38352453)
3. L. Ries, D. Melbert, and M. Krapcho SEER cancer statistics review, 1975-2000 2008 National Cancer Institute Bethesda (MD)
4. S.F. Altekruse, C. Kosary, and M. Krapcho SEER cancer statistics review, 1975-2007 2010 National Cancer Institute Available from: http://seer.cancer.gov/ csr/1975-2007/ Accessed June 7, 2011
5. C.A. Baughan, V.L. Hall, B.J. Leppard, and P.J. Perkins Follow-up in stage I cutaneous malignant melanoma: an audit Clin Oncol (R Coll Radiol) 5 1993 174 180 (Pubitemid 23218467)
6. A. Brobeil, D. Rapaport, K. Wells, C.W. Cruse, F. Glass, and N. Fenske Multiple primary melanomas: implications for screening and follow-up programs for melanoma Ann Surg Oncol 4 1997 19 23
7. T.J. Dicker, G.M. Kavanagh, R.M. Herd, T. Ahmad, K.M. McLaren, and U. Chetty A rational approach to melanoma follow-up in patients with primary cutaneous melanoma: Scottish Melanoma Group Br J Dermatol 140 1999 249 254 (Pubitemid 29111351)
8. M.F. Kalady, R.R. White, J.L. Johnson, D.S. Tyler, and H.F. Seigler Thin melanomas: predictive lethal characteristics from a 30-year clinical experience Ann Surg 238 2003 528 535
9. D.M. Moloney, D.J. Gordon, J.C. Briggs, and H.S. Rigby Recurrence of thin melanoma: how effective is follow-up? Br J Plast Surg 49 1996 409 413 (Pubitemid 26302626)
10. W.J. Poo-Hwu, S. Ariyan, L. Lamb, R. Papac, D. Zelterman, and G.L. Hu Follow-up recommendations for patients with American Joint Committee on Cancer stages I-III malignant melanoma Cancer 86 1999 2252 2258 (Pubitemid 30010365)
11. W.B. Goggins, and H. Tsao A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors Cancer 97 2003 639 643 (Pubitemid 36125840)
12. T.M. Johnson, T. Hamilton, and L. Lowe Multiple primary melanomas J Am Acad Dermatol 39 1998 422 427 (Pubitemid 28417378)
13. S. Kang, R.L. Barnhill, M.C. Mihm Jr., and A.J. Sober Multiple primary cutaneous melanomas Cancer 70 1992 1911 1916
14. A.B. Francken, E. Bastiaannet, and H.J. Hoekstra Follow-up in patients with localized primary cutaneous melanoma Lancet Oncol 6 2005 608 621 (Pubitemid 41051939)
15. U.R. Kleeberg Wishful thinking, unicentric empiricism and the everyday world of the medical melanomologist Melanoma Res 7 Suppl 1997 S143 S149
16. C. Garbe, A. Paul, H. Kohler-Spath, U. Ellwanger, W. Stroebel, and M. Schwarz Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy J Clin Oncol 21 2003 520 529 (Pubitemid 46606483)
17. C.E. Orfanos, E.G. Jung, G. Rassner, H.H. Wolff, and C. Garbe Position and recommendations of the Malignant Melanoma Committee of the German Society of Dermatology on diagnosis, treatment and after-care of malignant melanoma of the skin. Status 1993/94 [in German] Hautarzt 45 1994 285 291 (Pubitemid 24210329)
18. G. Cohn-Cedermark, L.E. Rutqvist, R. Andersson, M. Breivald, C. Ingvar, and H. Johansson Long-term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm Cancer 89 2000 1495 1501
19. C. Garbe A rational approach to the follow-up of melanoma patients Recent Results Cancer Res 160 2002 205 215
20. S.J. Soong, R.A. Harrison, W.H. McCarthy, M.M. Urist, and C.M. Balch Factors affecting survival following local, regional, or distant recurrence from localized melanoma J Surg Oncol 67 1998 228 233 (Pubitemid 28196912)
21. A.B. Francken, N.A. Accortt, H.M. Shaw, M.H. Colman, M. Wiener, and S.J. Soong Follow-up schedules after treatment for malignant melanoma Br J Surg 95 2008 1401 1407
22. U. Hofmann, M. Szedlak, W. Rittgen, E.G. Jung, and D. Schadendorf Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival Br J Cancer 87 2002 151 157
23. M. Weiss, C.L. Loprinzi, E.T. Creagan, R.J. Dalton, P. Novotny, and J.R. O'Fallon Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas JAMA 274 1995 1703 1705
24. M. Berwick, N. Dubin, S.T. Luo, and J. Flannery No improvement in survival from melanoma diagnosed from 1973 to 1984 Int J Epidemiol 23 1994 673 681 (Pubitemid 24260365)
25. L.A. DiFronzo, L.A. Wanek, and D.L. Morton Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up Cancer 91 2001 1520 1524 (Pubitemid 32319263)